38 reports

  • Global erectile dysfunction treatment market by product
  • Global ED treatment market by product 2015 and 2020
  • Dysfunction Drug
  • Boston Scientific Corporation
  • Coloplast Group
  • Eli Lilly & Co.
  • Pfizer Inc.
  • GLOBAL SEXUAL DYSFUNCTION DRUGS MARKET SEGMENTATION BY THERAPY 2016
  • GLOBAL SEXUAL DYSFUNCTION DRUGS MARKET 2016-2021 ($ MILLIONS)
  • Dysfunction Drug
  • Forecast
  • AbbVie Inc.
  • Eli Lilly & Co.
  • Pfizer Inc.

Key Features of the Report: - Erectile Dysfunction Patient Flow - Erectile Dysfunction Prevalence - Erectile Dysfunction Diagnosed Patients - Erectile Dysfunction Treated Patients

  • Dysfunction Drug
  • Therapy
  • Europe
  • World
  • Forecast

The primary treatment for erectile dysfunction is Viagra or a similar-acting drug.

  • Dysfunction Drug
  • Prosthesis
  • Therapy
  • World
  • Forecast

Marketed Drugs for Erectile Dysfunction, US, 2016 ##.

  • Dysfunction Drug
  • France
  • Germany
  • Italy
  • Japan

Key Features of the Report: - Erectile Dysfunction Patient Flow - Erectile Dysfunction Prevalence - Erectile Dysfunction Diagnosed Patients - Erectile Dysfunction Treated Patients

  • Dysfunction Drug
  • Europe
  • France
  • Germany
  • Forecast

It also provides a comprehensive understanding of the emerging Phase III therapies for Erectile Dysfunction which can turn out to be future prospective competitors for the marketed products.

  • Dysfunction Drug
  • Therapy
  • World
  • Demand
  • Product Initiative

Japan Erectile Dysfunction Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Erectile Dysfunction Treatments ##) Erectile Dysfunction Pipeline ##) Japan Erectile

  • Dysfunction Drug
  • Therapy
  • Japan
  • Market Shares

Marketed Drugs for Erectile Dysfunction, UK, 2016 ##.

  • Dysfunction Drug
  • Europe
  • France
  • Germany
  • Italy
  • FEATURES OF ERECTILE DYSFUNCTION PATIENTS
  • Prevalence of Erectile Dysfunction, males (000s)
  • Dysfunction Drug
  • Pharmaceutical
  • Therapy
  • Europe

UK Erectile Dysfunction Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Erectile Dysfunction Treatments ##) Erectile Dysfunction Pipeline ##) UK Erectile

  • Dysfunction Drug
  • Therapy
  • United Kingdom
  • Market Shares

Italy Erectile Dysfunction Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Erectile Dysfunction Treatments ##) Erectile Dysfunction Pipeline ##) Italy Erectile

  • Dysfunction Drug
  • Therapy
  • Italy
  • Market Shares

Germany Erectile Dysfunction Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Erectile Dysfunction Treatments ##) Erectile Dysfunction Pipeline ##) Germany Erectile

  • Dysfunction Drug
  • Therapy
  • Germany
  • Market Shares

France Erectile Dysfunction Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Erectile Dysfunction Treatments ##) Erectile Dysfunction Pipeline ##) France Erectile

  • Dysfunction Drug
  • Therapy
  • France
  • Market Shares

Spain Erectile Dysfunction Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Erectile Dysfunction Treatments ##) Erectile Dysfunction Pipeline ##) Spain Erectile

  • Dysfunction Drug
  • Therapy
  • Spain
  • Market Shares

US Erectile Dysfunction Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Erectile Dysfunction Treatments ##) Erectile Dysfunction Pipeline ##) US Erectile

  • Dysfunction Drug
  • Therapy
  • Market Shares

s Drugs by Share of Company Revenue (%), 2014 Figure ##. ## Bayer' s Drugs by Share of Company Revenue (%), 2014 Figure ##. ## Global Sexual Dysfunction Drugs Market: Regional Submarket Revenue Forecasts ($bn), 2015-2026 Figure ##. ## Global Sexual

  • Dysfunction Drug
  • Pharmaceutical
  • Therapy
  • World
  • Market Size

US Market Report for Erectile Dysfunction Devices 2016 - MedCore TABLE OF CONTENTS I LIST OF FIGURES III LIST OF CHARTS IV EXECUTIVE SUMMARY ## ##. ## U. S.

  • Dysfunction Drug
  • Therapy
  • United States
  • List of abbreviations
  • Highlights
  • Dysfunction Drug
  • Prosthesis
  • United States
  • World
  • Market Size

The total market for erectile dysfunction treatment devices includes inflatable erectile dysfunction devices and malleable erectile dysfunction devices.

  • Dysfunction Drug
  • Therapy
  • Europe
  • It is now widely recognized that sexual issues, particularly erectile dysfunction,...
  • Male sexual health issues are known to be due to a variety of reasons - frequently other underlying...
  • Cancer
  • Dysfunction Drug
  • Genitourinary System Disease
  • United Kingdom
  • PROVENGE group
  • Erectile Dysfunction - Overview
  • Erectile Dysfunction - Therapeutics Assessment
  • Dysfunction Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • Apricus Biosciences, Inc.
  • Erectile Dysfunction - Discontinued Products
  • Erectile Dysfunction - Drug Profiles
  • Dysfunction Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • Apricus Biosciences, Inc.
  • CF-602 - DRUG PROFILE
  • Adenosine Receptor A3 (ADORA3) - Featured News & Press Releases
  • Autoimmune Disease
  • Dysfunction Drug
  • United States
  • Product Initiative
  • Can-Fite BioPharma Ltd.
  • Futura Medical Plc, Major Products and Services
  • Consumer Healthcare (GSK) for the development of TPR100.
  • Dysfunction Drug
  • Healthcare
  • United States
  • Company Financials
  • Futura Medical plc
  • SMALL MOLECULE FOR SEXUAL DYSFUNCTION - DRUG PROFILE
  • SMALL MOLECULES TO AGONIZE DOPAMINE D2 RECEPTOR FOR SEXUAL DYSFUNCTION - DRUG...
  • Dysfunction Drug
  • Therapy
  • United States
  • Product Initiative
  • Apricus Biosciences, Inc.
  • Female Sexual Dysfunction - Drug Profiles
  • SMALL MOLECULE FOR SEXUAL DYSFUNCTION - DRUG PROFILE
  • Dysfunction Drug
  • United States
  • Litigation And Patent
  • Product Initiative
  • Palatin Technologies, Inc.
  • Palatin Technologies Raises USD16.5 Million in Public Offering of Units
  • EQUITY OFFERING
  • Dysfunction Drug
  • United States
  • Corporate Finance
  • Product Initiative
  • Palatin Technologies, Inc.
  • VIVUS, INC.: REGULATORY AND LEGAL EVENTS
  • VIVUS, INC.: RECENT DEVELOPMENTS
  • Dysfunction Drug
  • Pharmaceutical
  • United States
  • Company
  • VIVUS, Inc.

Erectile dysfunction Pipeline by Drug Class ##.

  • Dysfunction Drug
  • Therapy
  • Product Initiative